by Advize Admin | Feb 18, 2022 | OIG Files
In some of my recent posts, I have mentioned the term “carouselling,” as it pertains to the recycling of diabetic testing supplies. I have had several people inquire about this term and how the scheme works. Carouselling Is the purchasing and reselling of...
by Advize Admin | Feb 11, 2022 | FWA, OIG Files
I spent about 25 years in federal law enforcement, and most of that time was as a Senior Special Agent at HHS-OIG. I loved working there, and I loved doing healthcare fraud investigations. When I was exploring retirement, and what I was interested in doing...
by Advize Admin | Feb 4, 2022 | Compliance
Providers who are lucky enough to have their fraud, waste, and abuse matters resolved through a civil settlement (either via the US Attorney’s Office or the Office of Counsel to the Inspector General-a CMPL action), can sometimes have a clause in the settlement that...
by Advize Admin | Jan 14, 2022 | Healthcare
A new rule took effect recently that requires commercial payors to provide reimbursement for in-home COVID-19 testing, at a rate of eight (8) test kits per person, per month. Although well intended, the process for seeking reimbursement from commercial payors...
by Advize Admin | Jan 11, 2022 | OIG Files
For those of you who have been keeping up with the Elizabeth Holmes/Theranos trial, you likely have seen that there was a very mixed verdict. Holmes was convicted on some counts, acquitted on some and the jury was deadlocked on others. From a reader’s perspective, it...
Recent Comments